Process View
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of t cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-C | major histocompatibility complex, class I, C | 1.000 | Human | |
| HLA-A | major histocompatibility complex, class I, A | 0.999 | Human | |
| B2M | beta-2-microglobulin | 0.999 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.998 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.997 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.997 | Human | |
| CD80 | CD80 molecule | 0.973 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.872 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.819 | Human | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.594 | ||
| CD86 | CD86 molecule | 0.591 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.568 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.567 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.522 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.497 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.404 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.397 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.330 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.287 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.269 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 0.255 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.252 | ||
| IL8 | interleukin 8 | 0.243 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.243 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.233 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.214 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.192 | Human | |
| IL1B | interleukin 1, beta | 0.174 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.172 | ||
| TAPBP | TAP binding protein (tapasin) | 0.162 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.148 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.125 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.119 | Human | |
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.112 | ||
| FSTL1 | follistatin-like 1 | 0.111 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.105 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.099 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.096 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.093 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.092 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.091 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.086 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.084 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.080 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.074 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.072 | Human | |
| ADAM17 | ADAM metallopeptidase domain 17 | 0.069 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.065 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.063 | ||
| PLK3 | polo-like kinase 3 | 0.059 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.059 | ||
| IL10 | interleukin 10 | 0.056 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.055 | Human | |
| IDE | insulin-degrading enzyme | 0.053 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.052 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.051 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.050 | ||
| FPR3 | formyl peptide receptor 3 | 0.044 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.041 | ||
| APP | amyloid beta (A4) precursor protein | 0.040 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.037 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.036 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.034 | ||
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.033 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.031 | Human | |
| IL2RB | interleukin 2 receptor, beta | 0.030 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.030 | ||
| IFNG | interferon, gamma | 0.028 | ||
| PTAFR | platelet-activating factor receptor | 0.028 | ||
| HK3 | hexokinase 3 (white cell) | 0.027 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.024 | ||
| CD83 | CD83 molecule | 0.023 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.023 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.022 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.021 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.020 | Human | |
| C3 | complement component 3 | 0.020 | ||
| UBD | ubiquitin D | 0.020 | ||
| IL21R | interleukin 21 receptor | 0.019 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.019 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.018 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.018 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.018 | Human | |
| CD2 | CD2 molecule | 0.018 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.017 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.017 | ||
| IER3 | immediate early response 3 | 0.017 | ||
| TYMP | thymidine phosphorylase | 0.016 | ||
| CD163 | CD163 molecule | 0.016 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.016 | ||
| BCL2A1 | BCL2-related protein A1 | 0.016 | ||
| TNF | tumor necrosis factor | 0.016 | ||
| TAPBPL | TAP binding protein-like | 0.016 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.015 | ||
| CD28 | CD28 molecule | 0.015 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.014 | ||
| SLAMF8 | SLAM family member 8 | 0.014 | ||
| ENG | endoglin | 0.014 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.013 | Human | |
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.012 | Mouse | |
| IL2RA | interleukin 2 receptor, alpha | 0.012 | Mouse | |
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.012 | Human Rat | |
| CCL19 | chemokine (C-C motif) ligand 19 | 0.012 | Human | |
| SLAMF7 | SLAM family member 7 | 0.011 | ||
| BTN3A3 | butyrophilin, subfamily 3, member A3 | 0.011 | ||
| CH25H | cholesterol 25-hydroxylase | 0.011 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.010 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.010 | ||
| CCND1 | cyclin D1 | 0.010 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.010 |